Skip to Content

A625 (Permax 0.25 mg)

Generic Name: pergolide

Pill imprint A625 has been identified as Permax 0.25 mg.

Permax is used in the treatment of parkinson's disease; tourette's syndrome; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Permax 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Permax 0.25 mg A625
Discount Card Promo
Permax
Generic Name:
pergolide
Imprint:
A625
Strength:
0.25 mg
Color:
Green
Shape:
Rectangle
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Elan Pharmaceutical/Athena Neurosciences Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide